Abstract: Semiconductor structures and methods for manufacturing the same are provided. The semiconductor structure includes a first stack structure extends above the isolation structure, and the first stack structure includes a plurality of first nanostructures along a first direction. The semiconductor structure also includes a second stack structure formed adjacent to the first stack structure, and the second stack structure includes a plurality of second nanostructures along the first direction. A first dielectric wall between the first stack structure and the second stack structure, and the first dielectric wall is directly over a first portion of the isolation structure and surrounded by a second portion of the isolation structure, and a top surface of the first portion of the isolation structure is lower than a top surface of the second portion of the isolation structure.

Abstract: Semiconductor structures and processes are provided. A semiconductor structure of the present disclosure includes a first base portion and a second base portion extending lengthwise along a first direction, a first source/drain feature disposed over the first base portion, a second source/drain feature disposed over the second base portion, a center dielectric fin sandwiched between the first source/drain feature and the second source/drain feature along a second direction perpendicular to the first direction, and a source/drain contact disposed over the first source/drain feature, the second source/drain feature and the center dielectric fin. A portion of the source/drain contact extends between the first source/drain feature and the second source/drain feature along the second direction.

Abstract: Provided herein are opioid receptor modulators and pharmaceutical compositions comprising said compounds.

Abstract: A semiconductor structure includes: a substrate; a first fin and a second fin disposed on the substrate and spaced apart from each other; a dielectric wall disposed on the substrate and having first and second wall surfaces; a third fin disposed on the substrate to be in direct contact with at least one of the first and second fins; a first device disposed on the first fin and including first channel features extending away from the first wall surface; a second device disposed on the second fin and including second channel features extending away from the second wall surface; at least one third device disposed on the third fin and including third channel features; and an isolation feature disposed on the substrate to permit the third device to be electrically isolated from the first and second devices. A method for manufacturing the semiconductor structure is also disclosed.

Abstract: A semiconductor device and method of forming the same are disclosed. The semiconductor device includes a fin structure, a gate electrode, a source-drain region, a plug and a hard mask structure. The gate electrode crosses over the fin structure. The source-drain region in the fin structure is aside the gate electrode. The plug is disposed over and electrically connected to the gate electrode. The hard mask structure surrounds the plug and is disposed over the gate electrode, wherein the hard mask structure includes a first hard mask layer and a second hard mask layer, the second hard mask layer covers a sidewall and a top surface of the first hard mask layer, and a material of the first hard mask layer is different from a material of the second hard mask layer.

Abstract: A method for caching data, and a host device and a storage system that caches data. The method includes determining a first file in a storage device as a first predetermined type of file; reallocating a logical address of a predetermined logical address region to the first file; and updating a first logical address to physical address (L2P) table, corresponding to the predetermined logical address region, in a cache of the host device. The updated first L2P table includes a mapping relationship between the logical address reallocated for the first file and a physical address of the first file.

Abstract: A near-zero maintenance integrated purification device for drinking water supply of villages and towns and a method for treating source water using this device are provided to solve the multi-pollution problems caused by microorganisms, turbidity, iron, manganese, taste and odor, and organic matter in the drinking water sources of villages and towns. The device includes a small-spacing folding plate speed sink regulating water tank, a small diameter tube reactor, a granular active carbon (GAC) slow-speed filter tank, a gravity-driven ultrafiltration membrane tank and an ipsilateral U-turn corridor clean water tank. The near-zero maintenance integrated purification device is applicable to different types of water sources (e.g., groundwater, lake water, reservoir water, spring water, snowmelt water, cellar water and rain water, etc.), and could efficiently remove kinds of pollutants, improving the biological and chemical safety of drinking water.

Abstract: A circuit driving substrate, display panel and a display driving method are provided. The circuit driving substrate includes a pixel array, a first switching circuit, a second switching circuit, a first driving circuit and a second driving circuit. The first switching circuit is coupled to the pixel array through a plurality of gate lines, and receives a first switching signal. The second switching circuit is coupled to the pixel array through the gate lines, and receives a second switching signal. The first driving circuit is coupled to the first switching circuit and configured to output the first voltage signal to the first switching circuit. The second driving circuit is coupled to the second switching circuit and configured to output a second voltage signal to the second switching circuit. The first switching circuit and the second switching circuit selectively provide the first voltage signal or the second voltage signal.

Abstract: The present invention relates to an antigen-binding protein, or an antigen-binding fragment thereof, comprising (i) a heavy chain variable domain comprising a VHCDR1 having the amino acid sequence GYSITSGYSWH; a VHCDR2 having the amino acid sequence YIHYSGSTKYNPSLKS and a VHCDR3 having the amino acid sequence GSNYGFDY; and (ii) a light chain variable domain comprising a VLCDR1 having the amino acid sequence KSSQSLLYSNDQKNYLA, a VLCDR2 having the amino acid sequence WASIRES, and a VLCDR3 having the amino acid sequence QQYYIYPLT.

Abstract: A near-zero maintenance integrated purification device for drinking water supply of villages and towns and a method for treating source water using this device are provided to solve the multi-pollution problems caused by microorganisms, turbidity, iron, manganese, taste and odor, and organic matter in the drinking water sources of villages and towns. The device includes a small-spacing folding plate speed sink regulating water tank, a small diameter tube reactor, a granular active carbon (GAC) slow-speed filter tank, a gravity-driven ultrafiltration membrane tank and an ipsilateral U-turn corridor clean water tank. The near-zero maintenance integrated purification device is applicable to different types of water sources (e.g., groundwater, lake water, reservoir water, spring water, snowmelt water, cellar water and rain water, etc.), and could efficiently remove kinds of pollutants, improving the biological and chemical safety of drinking water.

Abstract: A scan output flip-flop includes a selection circuit, a control circuit, and a scan-out stage circuit. The selection circuit is controlled by a first test enable signal to transmit a data signal on a first input terminal or a test signal on a second input terminal to an output terminal to serve as an input signal. The control circuit is controlled by a first clock signal and a second clock signal to generate a first control signal and a second control signal according to the input signal. The scan-out stage circuit receives only one of the first control signal and the second control signal, and is controlled by the first test enable signal and a second test enable signal to generate a scan-out signal.

Abstract: A battery and a method of fabricating a porous membrane are disclosed. The battery includes an anode, a cathode, and a battery separator. The battery separator is positioned between the anode and the cathode and includes a macroporous substrate and a mesoporous silica thin film (MSTF) with perpendicular mesopore channels. The MSTF is positioned on the macroporous substrate. The method includes the following steps. A polymer film is formed on a macroporous substrate. A MSTF with perpendicular mesopore channels is grown on the polymer film. The polymer film is removed to form the porous membrane.

Abstract: A scan output flip-flop includes a selection circuit, a control circuit, and a scan-out stage circuit. The selection circuit is controlled by a first test enable signal to transmit a data signal on a first input terminal or a test signal on a second input terminal to an output terminal to serve as an input signal. The control circuit is controlled by a first clock signal and a second clock signal to generate a first control signal and a second control signal according to the input signal. The scan-out stage circuit receives only one of the first control signal and the second control signal, and is controlled by the first test enable signal and a second test enable signal to generate a scan-out signal.

Abstract: The present invention relates to antigen-binding proteins, or antigen-binding fragments thereof. In particular, the present invention relates to antigen-binding proteins, or antigen-binding fragments thereof that bind to ERBB2. Compositions comprising a physiologically acceptable carrier and a therapeutically effective amount of the antigen-binding protein, or antigen-binding fragment thereof, use of the antigen-binding protein, or antigen-binding fragment thereof, methods for detecting cancer as well as kits when used in such methods are also provided.

Abstract: A pixel structure includes a pixel electrode, a data selection line and an isolation line. The isolation line is disposed along the pixel electrode. The pixel electrode is configured to store a pixel voltage. The data selection line is configured to transmit a data signal. The isolation line is configured to reduce an influence of an electric field of the data signal on the pixel voltage of the pixel electrode. A projection area of the isolation line is overlapped with a projection area of the pixel electrode.

Abstract: The present invention relates to an antigen-binding protein, or an antigen-binding fragment thereof, comprising (i) a heavy chain variable domain comprising a VHCDR1 having the amino acid sequence GYSITSGYSWH; a VHCDR2 having the amino acid sequence YIHYSGSTKYNPSLKS and a VHCDR3 having the amino acid sequence GSNYGFDY; and (ii) a light chain variable domain comprising a VLCDR1 having the amino acid sequence KSSQSLLYSNDQKNYLA, a VLCDR2 having the amino acid sequence WASIRES, and a VLCDR3 having the amino acid sequence QQYYIYPLT.

Abstract: A touch sensor configured to sense a touch object is provided. The touch sensor includes a sensing device and a sensing circuit. The sensing device includes a substrate, a sensing electrode, a sensing common electrode and a shielding layer. The sensing electrode and the sensing common electrode are disposed on the substrate. The shielding layer is disposed on the sensing electrode and the sensing common electrode. The sensing circuit is electrically connected to the sensing device. The sensing circuit includes a resistor device. A relaxation frequency of a relaxation signal of the touch sensor is determined according to a resistance of the resistor device and/or a parasitic resistance of the sensing device. A pulse difference of the relaxation signal is changed by the touch object. The touch object is a conductor. An electronic paper display panel including the foregoing touch sensor is also provided.

Abstract: The present invention relates to antigen-binding proteins, or antigen-binding fragments thereof. In particular, the present invention relates to antigen-binding proteins, or antigen-binding fragments thereof that bind to ERBB2. Compositions comprising a physiologically acceptable carrier and a therapeutically effective amount of the antigen-binding protein, or antigen-binding fragment thereof, use of the antigen-binding protein, or antigen-binding fragment thereof, methods for detecting cancer as well as kits when used in such methods are also provided.

Abstract: A display device includes a selection line, a data line and plural pixel units. Each of the pixel units includes a first subpixel and a second subpixel. The second subpixel is disposed around the first subpixel and surrounds the first subpixel. The first subpixel includes a first capacitor, and the second subpixel includes a second capacitor. The selection line is configured to provide a selection signal. The data line is configured to provide a data signal. The first subpixel is configured to transmit the data signal to the first capacitor according to the selection signal, and the second subpixel is configured to transmit the data signal to the second capacitor according to the selection signal.

Abstract: The present invention relates to an antigen-binding protein, preferably a monoclonal antibody, against annexin A2 (ANXA2), comprising (i) a heavy chain variable domain comprising a VHCDR1 of sequence GYSITSGYSWH, a VHCDR2 of sequence YIHYSGSTKYNPSLKS and a VHCDR3 of sequence GSNYGFDY; and (ii) a light chain variable domain comprising a VLCDR1 of sequence KSSQSLLYSNDQKNYLA, a VLCDR2 of sequence WASIRES, and a VLCDR3 of sequence QQYYIYPLT. Also provided is an ANXA2 binding protein comprising (i) a heavy chain variable domain comprising a VHCDR1 of sequence VYSITSGYSWH; a VHCDR2 of sequence YIHYSGSTKYNPSLKS, and a VHCDR3 of sequence GTDNAVDY; and (ii) a light chain variable domain comprising a VLCDR1 of sequence KSSQSLLYSSNQKNYLA, a VLCDR2 of sequence WASSRES, and a VLCDR3 of sequence QQYYIYPLT. The antibodies preferably bind to an N-linked glycan on ANXA2, and are internalised upon binding. They may be conjugated with cytotoxins and may be used in the treatment or detection of cancer.